Spotlight on Testing: Utility of Genetic Testing for Mutations in the EIF2AK4 Gene in the Diagnosis of Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease
Originally published on August 12, 2014
Lecture Presenter
Hunter Best, PhD Medical Director, Molecular Genetics |
Dr. Best is a medical director of the Molecular Genetics Department at ARUP and an assistant professor of clinical pathology at the University of Utah School of Medicine. Dr. Best received his PhD in molecular and cellular pathology at the University of North Carolina School of Medicine and completed a fellowship in clinical molecular genetics at the Vanderbilt University Medical Center in Nashville. He is a member of the American Society for Investigative Pathology, Association for Molecular Pathology, and American Association for the Advancement of Science.
Sponsored by:
University of Utah School of Medicine, and ARUP Laboratories